Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats. 1997

M Dziedzicka-Wasylewska, and Z Rogóz
Department of Pharmacology, Polish Academy of Sciences, Kraków, Poland.

In the present study the hypothesis of antidepressant-induced subsensitivity of presynaptic dopamine receptors was readdressed. We used the behavioral model of low dose of apomorphine-induced locomotor hypoactivity in rats. Indeed, repeated administration of imipramine and citalopram attenuated the effect of low dose of apomorphine. However, the most interesting finding of the present study was the observation that similar and even stronger attenuation of low dose of apomorphine-induced hypoactivity was obtained by the acute treatment with imipramine, citalopram and amitriptyline, followed by 14 drug free days. That means that the acute antidepressant drug treatment seems to be sufficient to trigger the changes at the level of dopamine D2 presynaptic receptors and/or signal transduction mechanisms as a function of time, regardless of whether the drug is again administered. On the other hand, such the effect of time was not observed in the experiments using D-amphetamine as a motor stimulant. Only the repeated administration of antidepressant drugs enhanced the locomotor hyperactivity induced by D-amphetamine. Acute treatment, neither 2 h nor 14 days after the last dose, changed the D-amphetamine-induced hyperactivity. Such a difference in the time-dependent effects of antidepressant drugs on the locomotor activity induced by either the low dose of apomorphine or D-amphetamine may possibly result from the different mechanisms involved in the regulation of the biosynthesis of dopamine presynaptic and postsynaptic receptors in the rat brain.

UI MeSH Term Description Entries
D007099 Imipramine The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. Imidobenzyle,Imizin,4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2),Imipramine Hydrochloride,Imipramine Monohydrochloride,Imipramine Pamoate,Janimine,Melipramine,Norchlorimipramine,Pryleugan,Tofranil
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D000639 Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines. Amineurin,Amitrip,Amitriptylin Beta,Amitriptylin Desitin,Amitriptylin RPh,Amitriptylin-Neuraxpharm,Amitriptyline Hydrochloride,Amitrol,Anapsique,Apo-Amitriptyline,Damilen,Domical,Elavil,Endep,Laroxyl,Lentizol,Novoprotect,Saroten,Sarotex,Syneudon,Triptafen,Tryptanol,Tryptine,Tryptizol,Amitriptylin Neuraxpharm,Apo Amitriptyline,Desitin, Amitriptylin,RPh, Amitriptylin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D001058 Apomorphine A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. Apokinon,Apomorphin-Teclapharm,Apomorphine Chloride,Apomorphine Hydrochloride,Apomorphine Hydrochloride Anhydrous,Apomorphine Hydrochloride, Anhydrous,Apomorphine Hydrochloride, Hemihydrate,Britaject,Apomorphin Teclapharm
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015283 Citalopram A furancarbonitrile that is one of the SELECTIVE SEROTONIN REUPTAKE INHIBITORS used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia. Celexa,Citalopram Hydrobromide,Cytalopram,Lu-10-171,Seropram,Lu10171

Related Publications

M Dziedzicka-Wasylewska, and Z Rogóz
May 1999, Methods and findings in experimental and clinical pharmacology,
M Dziedzicka-Wasylewska, and Z Rogóz
January 1983, Psychopharmacology,
M Dziedzicka-Wasylewska, and Z Rogóz
November 1984, Pharmacology, biochemistry, and behavior,
M Dziedzicka-Wasylewska, and Z Rogóz
January 1985, Polish journal of pharmacology and pharmacy,
M Dziedzicka-Wasylewska, and Z Rogóz
September 1988, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
M Dziedzicka-Wasylewska, and Z Rogóz
September 1995, General pharmacology,
M Dziedzicka-Wasylewska, and Z Rogóz
January 1977, Communications in psychopharmacology,
M Dziedzicka-Wasylewska, and Z Rogóz
January 1991, Journal of neural transmission. General section,
Copied contents to your clipboard!